Published in Front Biosci (Landmark Ed) on January 01, 2010
The role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr (2012) 1.46
Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res (2010) 1.36
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.15
The role of cytokines in breast cancer development and progression. J Interferon Cytokine Res (2014) 0.95
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. PLoS One (2014) 0.94
Expression of TGFβ3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase/AKT signaling pathway. Clin Exp Metastasis (2012) 0.92
Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity. Breast Cancer Res (2012) 0.89
SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis. Oncotarget (2016) 0.86
Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells. PLoS One (2011) 0.86
Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells. Cell Death Dis (2013) 0.85
Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2. Clin Exp Metastasis (2011) 0.85
Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model. PLoS One (2012) 0.84
The impact of TGF-β1 on the mRNA expression of TβR I, TβR II, Smad4 and the invasiveness of the JEG-3 placental choriocarcinoma cell line. Oncol Lett (2012) 0.84
uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway. Cell Death Dis (2012) 0.84
Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer. Histopathology (2011) 0.82
Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells. PLoS One (2012) 0.82
Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis. J Proteome Res (2012) 0.81
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer. Oncotarget (2015) 0.81
In situ hybridization analysis of the expression of miR-106b in colonic cancer. Int J Clin Exp Pathol (2015) 0.79
In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis. Cancer Inform (2011) 0.79
The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition. PLoS One (2015) 0.79
MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7. J Cell Mol Med (2017) 0.77
P130cas is required for TGF-β1-mediated epithelial-mesenchymal transition in lung cancer. Oncol Lett (2014) 0.77
The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer. HPB (Oxford) (2010) 0.77
Relationships between SMAD3 expression and preoperative fluoropyrimidine-based chemoradiotherapy response in locally advanced rectal cancer patients. World J Surg (2015) 0.76
Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance. Int J Clin Exp Pathol (2015) 0.76
TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion. Int J Oncol (2017) 0.75
AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. Int J Cancer (2012) 2.24
Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention. Int J Cancer (2007) 1.21
Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem (2009) 1.19
Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem (2007) 1.18
Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update. Biochim Biophys Acta (2002) 1.14
Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front Biosci (Schol Ed) (2010) 1.12
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat (2010) 1.11
Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. Biochem J (2012) 1.04
Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression. Toxicol Sci (2007) 1.02
Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. Biochem Biophys Res Commun (2009) 1.00
Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update. Cell Tissue Res (2011) 0.96
Structure and promoter characterization of aldo-keto reductase family 1 B10 gene. Gene (2009) 0.93
Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels. Biochem Biophys Res Commun (2009) 0.93
Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds. Chem Biol Interact (2011) 0.93
AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group. Toxicol Appl Pharmacol (2011) 0.92
Transforming growth factor-beta signaling in breast cancer. Front Biosci (2007) 0.91
Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives. Recent Pat Anticancer Drug Discov (2009) 0.90
Role of aldo-keto reductases in development of prostate and breast cancer. Front Biosci (2006) 0.87
Thiol-disulfide exchanges modulate aldo-keto reductase family 1 member B10 activity and sensitivity to inhibitors. Biochimie (2010) 0.87
The origin of cancer stem cells. Front Biosci (Schol Ed) (2012) 0.85
Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway. Biochem J (2011) 0.84
Chemical genetics of acetyl-CoA carboxylases. Molecules (2013) 0.83
Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res (2011) 0.83
Efficient synthesis of RITA and its analogues: derivation of analogues with improved antiproliferative activity via modulation of p53/miR-34a pathway. Org Biomol Chem (2012) 0.82
Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10. Biol Chem (2010) 0.82
Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential. Recent Pat Anticancer Drug Discov (2012) 0.82
Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. Front Biosci (Elite Ed) (2012) 0.81
Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells. Mol Pharmacol (2006) 0.80
Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Breast Cancer Res Treat (2010) 0.78
Acridone derivative 8a induces oxidative stress-mediated apoptosis in CCRF-CEM leukemia cells: application of metabolomics in mechanistic studies of antitumor agents. PLoS One (2013) 0.78
Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes. J Biol Chem (2013) 0.76
Statil suppresses cancer cell growth and proliferation by the inhibition of tumor marker AKR1B10. Anticancer Drugs (2014) 0.76
Author's reply to: AKR1B10 and its emerging role in tumor carcinogenesis and as a cancer biomarker. Int J Cancer (2012) 0.76
Uridine phosphorylase in breast cancer: a new prognostic factor? Front Biosci (2006) 0.76
Dual role of insulin-like growth factor-1 in acetyl-CoA carboxylase-alpha activity in human colon cancer cells HCT-8: downregulating its expression and phosphorylation. Mol Cell Biochem (2011) 0.76
p38β, A novel regulatory target of Pokemon in hepatic cells. Int J Mol Sci (2013) 0.75
Editorial: anti-lipogenesis as a novel strategy for cancer therapy. Recent Pat Anticancer Drug Discov (2012) 0.75
[The model's establishment of the single cell (HepG2) clones over expressed ARL-1 gene]. Zhonghua Gan Zang Bing Za Zhi (2002) 0.75
Human aldo-keto reductases: structure, substrate specificity and roles in tumorigenesis. Biomol Concepts (2011) 0.75
Activation of Stat1, IRF-1, and NF-kappaB is required for the induction of uridine phosphorylase by tumor necrosis factor-alpha and interferon-gamma. Nucleosides Nucleotides Nucleic Acids (2010) 0.75